Bio LC Prepacked Affinity Columns

Gilson&rsquos reusable, silica-free centrifugal partition chromatography (CPC) columns offer high injection capacities of milligram to multi-kilograms resulting in 95% recoveries with 99% purity or better. Increased Savings CPC columns use

Gilson&rsquos reusable, silica-free centrifugal partition chromatography (CPC) columns offer high injection capacities of milligram to multi-kilograms resulting in 95% recoveries with 99% purity or better. Increased Savings CPC columns use

Gilson&rsquos reusable, silica-free centrifugal partition chromatography (CPC) columns offer high injection capacities of milligram to multi-kilograms resulting in 95% recoveries with 99% purity or better. Increased Savings CPC columns use

Gilson&rsquos reusable, silica-free centrifugal partition chromatography (CPC) columns offer high injection capacities of milligram to multi-kilograms resulting in 95% recoveries with 99% purity or better. Increased Savings CPC columns use

InformationCPI-637 CPI-637 is a selective and cell-active benzodiazepinone CBP/EP300 bromodomain inhibitor with IC50 values of 0.03 μM and 0.051μM for CBP and EP300 respectively in TR-FRET assay. It is highly selective against other bromodomains,

Cy3 &#8482 Maleimide Mono-Reactive Dye 5-Pack More selective method of antibody labeling that reduces the possibility of the label interfering with subsequent antibody-antigen reactions. Provides an alternative when CyDye &#8482 NHS Esters are

DescriptionWhen working on a pharmaceutical formulation, there are specific considerations to make and challenging hurdles to take before you can successfully launch your final drug product - formulation stability, release kinetics and

DescriptionWhen working on a pharmaceutical formulation, there are specific considerations to make and challenging hurdles to take before you can successfully launch your final drug product - formulation stability, release kinetics and

DescriptionWhen working on a pharmaceutical formulation, there are specific considerations to make and challenging hurdles to take before you can successfully launch your final drug product - formulation stability, release kinetics and

DescriptionWhen working on a pharmaceutical formulation, there are specific considerations to make and challenging hurdles to take before you can successfully launch your final drug product - formulation stability, release kinetics and

Specifically optimized for nucleic acid microarray labeling. Higher reactivity Cy3 &#8482 and Cy5 dyes: 40 000 pmol reactive dye per vial, at &gt75% reactive dye content.

A Certified Spiking Solution &#174 of D 6 -25-Hydroxyvitamin D3 (26,26,26,27,27,27-D 6 ) in ethanol at a concentration of 50 &#956g/mL. This new internal standard is suitable for critical quantitative applications in research and clinical